These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27568836)

  • 1. Evaluation of dose-dependent effects of the proteasome inhibitor bortezomib in human platelets.
    Koessler J; Etzel J; Weber K; Boeck M; Kobsar A
    Eur J Pharmacol; 2016 Nov; 791():99-104. PubMed ID: 27568836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of long-term proteasome inhibition on platelet responsiveness mediated by bortezomib.
    Klingler P; Niklaus M; Koessler J; Weber K; Koessler A; Boeck M; Kobsar A
    Vascul Pharmacol; 2021 Jun; 138():106830. PubMed ID: 33422688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of proteasome activity for activating and inhibitory signalling in human platelets.
    Koessler J; Schuepferling A; Klingler P; Koessler A; Weber K; Boeck M; Kobsar A
    Cell Signal; 2019 Oct; 62():109351. PubMed ID: 31260799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro.
    Avcu F; Ural AU; Cetin T; Nevruz O
    Thromb Res; 2008; 121(4):567-71. PubMed ID: 17910980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome proteolysis supports stimulated platelet function and thrombosis.
    Gupta N; Li W; Willard B; Silverstein RL; McIntyre TM
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):160-8. PubMed ID: 24177323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis.
    Gupta N; Li W; McIntyre TM
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2657-66. PubMed ID: 26471267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
    Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
    Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proteasome regulates collagen-induced platelet aggregation via nuclear-factor-kappa-B (NFĸB) activation.
    Grundler K; Rotter R; Tilley S; Pircher J; Czermak T; Yakac M; Gaitzsch E; Massberg S; Krötz F; Sohn HY; Pohl U; Mannell H; Kraemer BF
    Thromb Res; 2016 Dec; 148():15-22. PubMed ID: 27768934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1.
    Fan Y; You G
    Mol Pharmacol; 2020 Jun; 97(6):384-391. PubMed ID: 32234809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A High-Content Screening Assay for the Discovery of Novel Proteasome Inhibitors from Formosan Soft Corals.
    Ling XH; Wang SK; Huang YH; Huang MJ; Duh CY
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30347865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
    Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
    Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomib.
    Xu Y; Yang X; Chen Y; Chen H; Sun H; Li W; Xie Q; Yu L; Shao L
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2148-2152. PubMed ID: 29773504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory role of proteasome in determination of platelet life span.
    Nayak MK; Kulkarni PP; Dash D
    J Biol Chem; 2013 Mar; 288(10):6826-34. PubMed ID: 23329846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Proteasome Inhibitor Bortezomib Induces Apoptosis and Activation in Gel-Filtered Human Platelets.
    Ghansah H; Debreceni IB; Fejes Z; Nagy B; Kappelmayer J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet Proteasome Activity and Metabolism Is Upregulated during Bacterial Sepsis.
    Grundler Groterhorst K; Mannell H; Pircher J; Kraemer BF
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates.
    Marciniak SJ; Mascelli MA; Furman MI; Michelson AD; Jakubowski JA; Jordan RE; Marchese PJ; Frelinger AL
    Thromb Haemost; 2002 Jun; 87(6):1020-5. PubMed ID: 12083481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.